EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stability Engineering of Recombinant Secretory IgA

Kathrin Göritzer iD, Richard Strasser iD, Julian K-C Ma

International Journal of Molecular Sciences · 22.06.2024 · 25 (13) · 6856

DOI: 10.3390/ijms25136856 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.06.2024. Verfasst von Kathrin Göritzer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, 1190 Vienna, Austria. Hauptthemen laut MEDLINE: Immunoglobulin A, Secretory, Recombinant Proteins, Protein Stability, SARS-CoV-2. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, BBSRC, Sir Joseph Hotung Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Secretory IgA (SIgA) presents a promising avenue for mucosal immunotherapy yet faces challenges in expression, purification, and stability. IgA exists in two primary isotypes, IgA1 and IgA2, with IgA2 further subdivided into two common allotypes: IgA2m(1) and IgA2m(2). The major differences between IgA1 and IgA2 are located in the hinge region, with IgA1 featuring a 13-amino acid elongation that includes up to six O-glycosylation sites. Furthermore, the IgA2m(1) allotype lacks a covalent disulfide bond between heavy and light chains, which is present in IgA1 and IgA2m(2). While IgA1 demonstrates superior epitope binding and pathogen neutralization, IgA2 exhibits enhanced effector functions and stability against mucosal bacterial degradation. However, the noncovalent linkage in the IgA2m(1) allotype raises production and stability challenges. The introduction of distinct single mutations aims to facilitate an alternate disulfide bond formation to mitigate these challenges. We compare four different IgA2 versions with IgA1 to further develop secretory IgA antibodies against SARS-CoV-2 for topical delivery to mucosal surfaces. Our results indicate significantly improved expression levels and assembly efficacy of SIgA2 (P221R) in Nicotiana benthamiana. Moreover, engineered SIgA2 displays heightened thermal stability under physiological as well as acidic conditions and can be aerosolized using a mesh nebulizer. In summary, our study elucidates the benefits of stability-enhancing mutations in overcoming hurdles associated with SIgA expression and stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin A, SecretoryRecombinant ProteinsProtein StabilitySARS-CoV-2HumansNicotianaProtein EngineeringCOVID-19

Stichwörter der Autor:innen

IgAaerosolizationantibody engineeringmonoclonal antibodyplant molecular pharmingprotein assemblyprotein stabilitysecretory immunoglobulin A

Substanzen

Immunoglobulin A, SecretoryRecombinant Proteins

Autor:innen und Institutionen

  • Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, 1190 Vienna, Austria.
  • Institute for Infection and Immunity, St. George's University of London, London SW17 0RE, UK.

ORCID-Profile: Kathrin Göritzer, Richard Strasser

Förderung

  • Austrian Science Fund
  • BBSRC
  • Sir Joseph Hotung Charitable Trust

Zitieren

APA

Göritzer, K., Strasser, R., & Ma, J. K. (2024). Stability Engineering of Recombinant Secretory IgA. International Journal of Molecular Sciences, 25(13), 6856. https://doi.org/10.3390/ijms25136856

Vancouver

Göritzer K, Strasser R, Ma JK. Stability Engineering of Recombinant Secretory IgA. International Journal of Molecular Sciences. 2024;25(13):6856. doi:10.3390/ijms25136856

BibTeX
@article{Gritzer2024,
  author = {Göritzer, Kathrin and Strasser, Richard and Ma, Julian K-C},
  title = {Stability Engineering of Recombinant Secretory IgA},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {13},
  pages = {6856},
  doi = {10.3390/ijms25136856}
}
Kostenlos starten →